1478 related articles for article (PubMed ID: 27626896)
1. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
[TBL] [Abstract][Full Text] [Related]
2. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Salehi B; Goudarzi H; Nikmanesh B; Houri H; Alavi-Moghaddam M; Ghalavand Z
J Infect Chemother; 2018 Jul; 24(7):515-523. PubMed ID: 29555392
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
4. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R
Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166
[TBL] [Abstract][Full Text] [Related]
5. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
6. [Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].
Ciftci IH; Aşık G; Karakeçe E; Oksüz L; Yağcı S; Sesli Çetin E; Ozdemir M; Atasoy AR; Koçoğlu E; Gül M; Kurtoğlu MG; Köksal Çakırlar F; Seyrek A; Berktaş M; Gültepe B; Ayyildiz A
Mikrobiyol Bul; 2013 Oct; 47(4):592-602. PubMed ID: 24237428
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
Seifert H; Stefanik D; Sutcliffe JA; Higgins PG
Int J Antimicrob Agents; 2018 Jan; 51(1):62-64. PubMed ID: 28705668
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L
J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance among Acinetobacter baumannii isolates from Iran: changes in antimicrobial susceptibility patterns and genotypic profile.
Bahador A; Raoofian R; Taheri M; Pourakbari B; Hashemizadeh Z; Hashemi FB
Microb Drug Resist; 2014 Dec; 20(6):632-40. PubMed ID: 25029126
[TBL] [Abstract][Full Text] [Related]
10. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
[TBL] [Abstract][Full Text] [Related]
11. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
[TBL] [Abstract][Full Text] [Related]
12. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Extensively Drug-Resistant blaOXA-23-Producing Acinetobacter baumannii Spread in a Greek Hospital.
Mavroidi A; Katsiari M; Palla E; Likousi S; Roussou Z; Nikolaou C; Platsouka ED
Microb Drug Resist; 2017 Jun; 23(4):488-493. PubMed ID: 27728770
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23-like and blaOXA-24-like genes: A multicenter based study.
Khanjani S; Sedigh Ebrahim-Saraie H; Shenagari M; Ashraf A; Mojtahedi A; Atrkar Roushan Z
Acta Microbiol Immunol Hung; 2020 Mar; 67(3):182-186. PubMed ID: 32160785
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
[TBL] [Abstract][Full Text] [Related]
17. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
Cakirlar FK; Ciftci IH; Gonullu N
Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073
[TBL] [Abstract][Full Text] [Related]
18. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
19. Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China.
Li Y; Guo Q; Wang P; Zhu D; Ye X; Wu S; Wang M
J Microbiol Immunol Infect; 2015 Feb; 48(1):101-8. PubMed ID: 24863499
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
